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Abstract
Background: Timely diagnosis and early initiation of life-saving antiretroviral therapy are critical factors in
preventing mortality among HIV-infected infants. However, resource-limited settings experience numerous
challenges associated with centralised laboratory-based testing, including low rates of testing, complex sample
referral pathways and unacceptably long turnaround times for results. Point-of-care (POC) HIV testing for HIV-
exposed infants can enable same-day communication of results and early treatment initiation for HIV-infected
infants. However, complex operational issues and service integration can limit utility and must be well understood
prior to implementation.
We explored and documented the challenges and enabling factors in implementing the POC Xpert® HIV-1 Qual
test (Cepheid, Sunnyvale, CA, USA) for early infant diagnosis (EID) as part of routine services in four public hospitals
in Myanmar.
Methods: This sub-study was part of a randomised controlled stepped-wedge trial (Australian and New Zealand
Clinical Trials Registry, number 12616000734460) designed to investigate the impact of POC testing for EID in
Myanmar and Papua New Guinea. Infants recruited during the intervention phase underwent POC testing at the
participating hospitals as part of routine care. Semi-structured interviews with 23 caregivers, 12 healthcare providers
and 10 key informants were used to explore experiences of POC-EID testing. The research team and hospital staff
documented and discussed implementation challenges throughout the study.
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Results: Overall, caregivers and healthcare workers were satisfied with the short turnaround time of the POC test.
Occasional delays in POC testing were mostly attributable to late receipt of samples by laboratory technicians and
communication constraints among healthcare staff. Hospital staff valued technical assistance from the research
group and the National Health Laboratory. Despite staff shortages and infrastructure challenges such as unreliable
electricity supply and cramped space, healthcare workers and caregivers found the implementation of the POC test
to be feasible at pilot sites.
Conclusions: As plans for national scale-up evolve, there needs to be a continual focus on staff training,
communication pathways and infrastructure. Other models of care, such as allowing non-laboratory-trained
personnel to perform POC testing, and cost effectiveness should also be evaluated.
Keywords: Point-of-care, Early infant diagnosis, HIV, Viral load, GeneXpert, Prevention of mother-to-child
transmission, ART initiation, Implementation science, Myanmar
Contributions to the literature
 Point-of-care (POC) tests can improve rates of early
diagnosis of HIV in infants, but can be challenging
to implement in resource-limited settings
 POC implementation studies to date have occurred
in high-burden countries with high caseloads of
HIV-exposed infants; Myanmar’s facilities have low
caseloads so staff are less experienced in testing and
referral procedures, presenting new challenges
 This is the first study to show the feasibility of
implementation of POC HIV testing for infants in
routine healthcare services in a low-caseload
environment
 POC HIV early infant diagnosis testing was found to
be feasible and acceptable to both caregivers and
healthcare workers
Background
In 2017, an estimated 1.8 million children below 15 years
of age were living with HIV globally; 180,000 of whom
were newly infected [1]. Without antiretroviral treatment
(ART), half of all children with HIV die before they turn
2 years old, with as many as a third dying within the first
year of life [2–5]. Early diagnosis of HIV-infected infants
and initiation of ART is critical to reducing HIV related
morbidity and mortality. Despite World Health
Organization (WHO) recommendations that all HIV-
exposed infants receive a virological test (DNA or RNA)
by the age of 6 weeks (4–6 weeks) [6, 7], in 2016, less
than half (43%) of all infants born to HIV-positive
mothers worldwide were tested within this timeframe
[8]. In Myanmar, only 28% of exposed infants had HIV
testing before 2 months of age in 2017 [9, 10].
Myanmar has an estimated HIV prevalence of 0.7%
[11]. There were 11,000 children aged 0–14 living
with HIV, and less than 500 deaths due to AIDS
among children within the same age group [11]. Pre-
vention of mother-to-child transmission of HIV
(PMTCT) programs have achieved coverage rates of 78%
of HIV-infected pregnant women, although localised eval-
uations have found that despite 88% of pregnant women
being initiated onto a regimen of antiretrovirals, only 59%
received ART for more than 8 weeks before delivery and
one in eight women did not receive any ART before deliv-
ery [12]. According to UNICEF, only about half of the
new-born (47%) received nevirapine syrup for prevention
of mother-to-child transmission [13], resulting in a verti-
cal transmission rate of about 17% [11]. These figures
highlight the critical importance of a functional and effect-
ive early infant diagnosis (EID) testing and treatment pro-
gram in reducing infant deaths. In one study, long test
result turnaround times (> 7 weeks) were documented for
36% of babies, with a further 33% never receiving their re-
sult, and this was worse for those living further from a
centralised laboratory [14]. Another evaluation indicated
that only 47% of babies received timely EID (before 8
weeks of age), with 27% experiencing a delay in sample
collection, and 26% never getting tested [15].
Many of the challenges associated with the effective
delivery of an EID program can be negated by
employing point-of-care (POC) technologies. These
molecular platforms are designed to be simple and
quick to operate in settings with only basic infrastruc-
ture and can eliminate sample transport issues and
reduce turnaround times, often permitting same-day
results. This can enable earlier ART initiation for
HIV-positive infants, improved linkage to care and re-
duced loss to follow-up [16–19]. To date, two POC
technologies have received WHO pre-qualification for
HIV infant diagnosis, the GeneXpert HIV-1 Qual
assay (Cepheid, Sunnyvale, CA, USA) and the Alere q
HIV-1/2 Detect (Alere Healthcare, Waltham, Massa-
chusetts, USA). While they are not as simple as
lateral-flow HIV antibody diagnostic tests, these small
molecular testing platforms can diagnose HIV in less
than 2 h, and only require minimally trained
personnel, ambient room temperatures, reliable
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electricity supply, and effective waste disposal systems.
Many studies have assessed the feasibility and field
performance of these two POC technologies in the
EID context, reporting accurate performance com-
pared to gold standard laboratory-based testing, and
high acceptability to health services and end users
[17, 20–23]. However, operational challenges – in-
cluding those associated with the physical environ-
ment, staff time, supervision and monitoring,
engaging the manufacturer, and communicating re-
sults – have been observed [17, 18, 20–23].
It is important to note that implementation studies to
date have occurred in high-burden countries with sig-
nificant caseloads of HIV-exposed infants (~ 23%) [17].
This contrasts with Myanmar, where there were an esti-
mated 752 new HIV infections due to mother-to-child
transmission in 2017 [13] and most facilities have rela-
tively low caseloads (2–7 cases per month) and thus
have less practice in testing procedures and referral
pathways. The implementation challenges and efficien-
cies of POC EID are likely to be significantly different
between low and high caseload settings.
Locally informed evidence is essential for key stake-
holders and policy makers to inform the effective imple-
mentation and wider scale-up of POC testing in the EID
program in Myanmar to increase testing rates and im-
prove linkage to care. This is the first study to assess the
implementation challenges and enabling factors associ-
ated with the introduction of the Xpert HIV-1 Qual test
in Myanmar’s public health system.
Methods
Study design
This qualitative field evaluation was part of a larger
multi-country cluster-randomised pragmatic stepped-
wedge trial (Australian and New Zealand Clinical Trials
Registry, number 12616000734460), which assessed the
effectiveness of implementing the POC Xpert® HIV-1
Qual assay for EID of HIV. In this design, the interven-
tion EID test was introduced at each hospital in a rando-
mised stepwise fashion until all hospitals were providing
the same POC service. Before commencing the interven-
tion, each site had a one-month transition period, during
which no enrolment occurred and when staff were
trained, equipment was installed and participant flow
and logistics were organised. The study duration was 19
months, between October 2016 and June 2018, with par-
ticipants enrolled over a 13-month period.
Study setting and sites
The study took place at four government hospitals in
and around Yangon, the biggest city and former capital
of Myanmar. The furthest hospital was located 20 km
from the National Health Laboratory (NHL – the
reference laboratory). Hospitals were eligible for partici-
pation if they: i) offered antenatal HIV screening to
pregnant women, (ii) provided services for laboratory-
based polymerase chain reaction tests for EID, (iii) had
an estimated caseload of at least three HIV-exposed in-
fants attending each month; (iv) had the capacity, or po-
tential capacity, to follow infants for at least 6 months
after delivery, and (v) had access to long-term HIV care
services, including ART, so that HIV-infected children
who met national criteria for treatment during the study
would have immediate and accelerated access to
treatment.
The participating hospital sites were South Okkalapa
Women’s and Children’s Hospital (200 beds), Central
Women’s Hospital (500 beds), Thanlyin General Hos-
pital (200 beds) and Thingangyun General Hospital (800
beds). All four hospitals had PMTCT services integrated
into routine antenatal care services. Following delivery,




Most HIV-infected mothers were screened for study eli-
gibility and recruited during their hospital stay following
childbirth, and additional recruitment took place with
caregivers during the infants’ follow-up visit to the
PMTCT clinic. Study staff explained the study to inter-
ested caregivers and obtained written informed consent
prior to enrolment.
Caregivers 18 years or older with a newborn infant
were eligible for participation in the study if: a) the par-
ent/caregiver resided within the site-specific catchment
area and was willing to provide reliable contact informa-
tion; b) infant(s) were born to confirmed HIV-infected
mothers and were within the first 28 days of life; c) the
parent/caregiver was able and willing to give informed
consent for enrolment of their infant in the study, and
permitted a member of the research team to remind
them to re-attend the clinic.
Near the end of the study, convenience sampling was
used to recruit participants who had received both
standard care and POC EID tests for qualitative inter-
views. Caregivers who had different experiences from
others in terms of repeated blood withdrawal, testing
and delayed receipt of results were also purposely invited
to participate in the interviews. In-depth interviews were
conducted with a total of 23 caregivers.
Healthcare workers and key informants
Hospital-based medico-social workers, laboratory techni-
cians and paediatricians involved in the study implemen-
tation were invited to participate in qualitative
interviews, and all 12 invitees consented to participate.
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Ten key informants were also interviewed. These were
people who were knowledgeable and influential about
EID testing and HIV treatment from the four study hos-
pitals, the National AIDS Program and the NHL.
Study procedures
Standard of care EID testing
We followed national standard operating procedures for
participants enrolled during the control and intervention
phases. Briefly, six dried blood spots were taken from
the heel or big toe of the infant, and in exceptional cir-
cumstances from venepuncture. Hospital staff trans-
ported the samples, usually the following day or after a
few days, to the NHL in Yangon, where they were tested
with the Abbott RealTime HIV-1 qualitative assay (Ab-
bott, Abbott Park, Illinois, USA). At the same time, hos-
pital staff collected the printed result forms of previously
tested samples from NHL. The results were then given
to the caregivers at their next follow-up appointment at
the hospital.
Intervention phase EID testing
In addition to the standard of care testing described
above, participants in the intervention phase were tested
with the Xpert HIV-1 Qual assay onsite at the hospital
laboratory and results integrated into routine services.
For this test, 200 μL of capillary or venous blood was
collected into EDTA tubes and a trained laboratory
technician from the hospital performed the test on the
same day, or the following day, depending on their
workload and availability. The paper-based Xpert HIV-1
Qual results were recorded and supplied to the consult-
ing doctors or paediatricians and then provided to the
caregivers on the same day or at the scheduled appoint-
ment within a week if participants could not wait for the
results.
Data collection from caregivers and healthcare workers
Researchers who were not involved in the implementa-
tion of the trial conducted semi-structured interviews
with 23 caregivers (22 mothers and one aunt), 12 health-
care workers and 10 key informants to explore the feasi-
bility and acceptability of the POC testing. The
interviews were guided by semi-structured interview
guides (see Additional files 1 and 2) developed particu-
larly for this study and took between 45min to 1 h. The
study procedures, risks and benefits were explained to
the participants and written informed consent was
obtained from all participants.
Implementation challenges were observed, and poten-
tial ways to overcome them proposed, and recorded in a
spreadsheet by the research coordinator throughout the
study period. Emerging challenges and alternative strat-
egies were discussed with the study staff during the
fortnightly monitoring visits with the research coordin-
ator in order to refine the testing process.
Data management and analysis
Recordings of interviews with caregivers and healthcare
staff were transcribed and translated into English by the
qualitative researchers who conducted the interviews.
The research coordinator analysed the translated tran-
scripts, using QSR International’s NVivo 12 qualitative
data analysis software (QSR International Pty Ltd., Mel-
bourne, Australia). Both deductive and inductive analysis
methods were applied to identify themes within the data.
Themes derived from participant responses were cross-
checked with the observed data recorded by the research
coordinator, and relevant quotes from participants were
extracted to support the themes of the observational
data and meeting notes.
In 2018, UNICEF outlined the key considerations for
introducing new POC diagnostic technologies into na-
tional health systems [24]. In analysing the results of our
study, we applied these key principles when comparing
the benefits and challenges of POC technologies com-
pared with conventional laboratory systems. (outlined in
Table 1).
Ethics
Ethical approval was obtained from the Ethical Review
Committee of the Department of Medical Research (Eth-
ics/DMR/2016/115) in Myanmar. In Australia, ethics ap-
proval was obtained from the Alfred Hospital Ethics
Committee (Project 500/14).
Results
This study identified the key factors in the successful im-
plementation of POC testing for EID in four public hos-
pitals in Myanmar. Note that a comparative analysis of
cost was beyond the scope of the study. Following the
UNICEF comparator framework, we will discuss our
results under the following themes: access, efficiency,
operability and infrastructure.
Access
Dedicated PMTCT clinics facilitated access to the Xpert
HIV-1 Qual assay. One site offered a dedicated clinic
once a week, two sites offered a clinic for HIV-positive
mothers once a month, and the fourth site had no set
PMTCT clinic dates. More frequent PMTCT clinics im-
proved the efficiency of identification and enrolment of
infants requiring HIV testing and provision of test
results.
In the intervention phase, laboratory technicians usu-
ally performed the POC EID on the same day as the
doctor’s consultation, taking about 90 min to produce a
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result. Caregivers generally waited at the hospital to re-
ceive the result on the same day.
I was told that I would receive the result at 3:30 pm.
I am very pleased that my baby was tested and [I]
knew the result quickly. (Mother, lives in Thaketa)
Same-day result delivery was acceptable to most care-
givers, particularly considering the travel time experi-
enced by some.
I came by bus since 9:30 am in the morning. The
bus took so long. So, I need to come 3 hours earlier
(laughing). When I arrived here it was 12:30 pm.
(Mother, lives in Dagon Satekan)
Results were not always returned on the same day and
39% (9/23) of the participating caregivers did not receive
the result on the testing day. Laboratory staff were
sometimes unable to test the EID sample upon receipt
due to competing urgent tasks or because some PMTCT
clinics ran late in the afternoon, with samples being re-
ceived too close to closing time. To overcome this chal-
lenge, the healthcare providers encouraged the
caregivers with infants due to have EID testing to arrive
at the clinic early on that day so that the laboratory
received the samples in time.
We also identified additional challenges associated
with the existing EID system. While the integrated
healthcare service – made up of paediatricians and an
HIV team including a medical officer, nurse, counsellor
and laboratory technicians – provided comprehensive
care to HIV-infected mothers and their infants, there
were instances of delays in timely EID testing (both
standard of care and POC) and return of results owing
to poor communication within these structures. Health-
care providers were given a chance to discuss these com-
munication gaps during the study staff meetings and the
site monitoring visits of the research coordinator and
developed communication pathways.
No, they (HIV team) don’t give the request form to
us. If we can’t provide the form, [the laboratory tech-
nician] did not accept to do the test. The team did
not hand over the information to each other.
(Medico-social worker, male)
Efficiency
Throughput of the Xpert POC EID test is limited by the
number of modules in the platform, which in the case of
this study, was two at each site. This reduced the num-
ber of tests that could be performed in one afternoon
session to a maximum of four and resulted in an inabil-
ity to return results the same day for some participants.
“I arrived around one pm at the clinic and had the
blood sample taking quickly. The lab will be closed
at two pm and there were two patients ahead of me.
They asked me to come after three days (to take the
result). (Mother, lives in North Dagon)
Another limitation was that there was only one Cepheid
distributor of Xpert cartridges in Myanmar. In one in-
stance, our most distant hospital experienced a break-
down of the machine, which then had to be moved to
the research office because the distributor did not pro-
vide technical assistance that far outside Yangon. The
ordering and receipt of Xpert HIV tests took 2–3
months, and the short expiry date of cartridges
(6 months at the time of the study), combined with a
low caseload, limited the ability to place large orders.
This resulted in frequent orders, requiring significant
human resources to place and follow up.
Smaller machine issues could be fixed by trained re-
search staff. Staff involved in the implementation found
this to be an effective solution to the issues.
Table 1 Summary of benefits and challenges of implementing Xpert®HIV-1 Qual at the hospital setting
Benefits Challenges/Limitations
Access • Specific PMTCT clinic day for HIV-infected mothers
• Shorter turnaround time (same-day results in some
study sites)
• Early receipt of results by patients
• Time constraint with PMTCT clinic opening hours in the afternoon
• Communication among multi-level healthcare staff required in the process
of testing and result return
• Logistical constraint (purchase of Xpert®HIV-1 Qual cartridges)
Efficiency • Short testing time
• Early receipt of results by healthcare workers led to
early initiation of ART
• A system for communicating EID testing and results to
patients by healthcare staff and among healthcare staff
• Low throughput of POC test (two samples can be run at a time although
instruments with higher capacity such as four-module device are available
• The distributor does not provide technical assistance in some locations
Operability • Workforce of medico-social workers was advantageous
for adherence counselling and patient follow-up
• Simple procedures of POC test
• Accessible refresher training and technical assistance
• Staff shortages and competing workloads
• Infrequent running of POC test
• Basic computer literacy
Infrastructure • Minimal requirement for a system for sample and
result transport
• Cramped space for staff and patients
• Irregular electricity supply
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If we had problem we called to Burnet [research
team] and asked how to solve it. Sometimes, the
error was encountered while the test is running for
about one hour. In that case, Burnet staff came to us
immediately and helped us. (Laboratory technician,
female)
Operability
The hospitals’ laboratory staff varied in qualifications
and capabilities. Medical technologists, with a four-year
training degree, generally took less time to become ac-
customed to the POC testing procedures, including
quality assurance and maintenance, than the less quali-
fied laboratory technicians with diploma degrees. A lack
of experience in using computer technology made some
laboratory technicians less confident in handling the
Xpert testing device, particularly the linked laptop. This
challenge diminished over time with practice and by
pairing with other staff familiar with the technology.
Because I had to use the Xpert machine just once a
month, I sometimes forgot the procedure [computer
operation] so, I wrote down the operating steps in
my notes. Sometimes, I had to call [laboratory coord-
inator]. I also printed out the test procedure.
(Laboratory technician, female)
Overall, however, both medical technologists and less
qualified staff found the test acceptable and easy to use.
No difficulty. Fine. It is like a routine test for me. Not
complicated for me. (Laboratory technician, female)
Anyway, the test is simple so that it is feasible. No
special training needed for blood sample taking as
well as preparation of the sample using the test. The
important part is maintenance and care for the ma-
chine. The operators should be skilled for it. (Paedia-
trician, female)
Our study highlighted the critical importance of select-
ing the right human resources to support the implemen-
tation of POC testing. Medico-social workers, who
helped both patient care and the social aspects of care-
givers and infants, were essential in minimising loss to
follow-up. They also facilitated communication between
patients and healthcare staff and played an important
role in the coordination of testing.
I asked the clients to inform me in advance when
they are coming for the test after their child turns
forty-five days. Then I can confirm with them [HIV
team] and the lab person if they are available.
(Medico-social worker, male)
We did note that a shortage of staff, high workloads and
complex task-sharing were often associated with unclear
responsibilities regarding the POC testing and test result
delivery process. Laboratory staff highlighted concerns
about human resources in interviews.
It can be solved with increased human resource.
[laughs] My workload is a bit tight with the current
setting. Because I have both hospital workload and
the test with the study. (Laboratory technician,
female)
Infrastructure
The availability of the POC device reduced the complex
and sometimes ad hoc arrangements that were in place
for the delivery of dried blood spots to the NHL and the
collection of results.
[There is] no regular schedule for transporting sam-
ples to the National Health Laboratory ... three to
four samples were sent together. [There are] no
assigned staff for sample transport so it is random
and up to the chance of a person going to the [refer-
ence] laboratory. (Laboratory technician, female)
We just need to put the cartridge and the machine
runs itself. In the meantime, we can work for other
tasks. When it is ready, we just go to machine and
get the result. (Laboratory technician, female)
The POC device, the computer, and storage for the car-
tridges require considerable space. This was a major
issue at one study site which initially had to set the de-
vice up in its lunch room. The research coordinator had
several discussions with laboratory staff and a medical
superintendent until a proper and fixed place was
located for the device in the laboratory.
It (GeneXpert device) is close to our lunch table in
other side of the room, our meal at one side. We had
challenge in enough space to put the machine in, as
the rooms were a bit small. Now it has moved to an-
other room. (Laboratory technician, female)
During the implementation of this study, the hospital
sites were not required to store more than 20 cartridges
onsite, because these could be provided regularly by the
study office. This reduced the amount of storage space
required at each test site, but this will need consider-
ation if testing is scaled up.
Irregular electricity supply was a problem, and al-
though steps were taken to negate this with the installa-
tion of an uninterruptible power source, voltage
variation caused problems in some test runs.
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I think it was because of the interrupted power sup-
ply. When the QC [Quality Control] was run, the
power was off. So, the QC didn’t work well. (Labora-
tory technician, female)
Discussion
This is the first study to investigate the implementation
of POC EID testing in routine services at public hospi-
tals in Myanmar. Across these four pilot sites, POC HIV
EID testing was found to be feasible and acceptable to
both caregivers and healthcare workers. Implementation
was not without its challenges; infrastructure issues, the
need for continual training and developing an appropri-
ate model of care and communication pathway were
highlighted.
Staff found the POC test simple, convenient and easy
to use. It circumvented many of the logistical challenges
associated with transporting samples and collecting re-
sults from the NHL. This finding is comparable to that
of a study in Cape Town where the providers considered
POC technology was simple and easy [21]. It, however,
introduced new challenges associated with clinic time
management, with some results not being returned on
the same day as the consultation because the blood sam-
ples were received too late in the day for processing or
the Xpert operator was not available. Approaches such
as clear communication channels and specifically sched-
uling appointments for HIV-exposed infants based on
the availability of the Xpert machine, operator and
healthcare worker need to be considered and structured
accordingly if testing is to be efficient. A study in South
Africa about HIV testing at point-of-care found that
maintaining relationships among healthcare providers
was critical to ensure sufficient stock of equipment and
test kits, good communication and to manage high
workload [20].
While all staff were trained in the operation of the
Xpert device, the low caseload of HIV-exposed infants at
each site limited the experience of each operator in con-
ducting the test, and this was further complicated by the
need to operate a linked computer. High-quality and
clear standard operating procedures, frequent refresher
training, and a comprehensive quality system are critical
factors in ensuring competence. Similar to the findings
of a study in Zimbabwe [25], staff with basic computer
literacy quickly gained competency to operate the device.
For staff with little computer literacy working in a low-
caseload remote setting, a POC device with simpler pro-
cedures than the Xpert® HIV-1 Qual, such as the
GeneXpert Omni single-module device, is an alternative.
Infrastructure issues, predominantly reliable electricity
supply, were evident at these sites, and need consider-
able thought as the country considers scale-up of decen-
tralised HIV testing. Additionally, space for the machine
was a problem at one site in this study, although there
were no issues with the storage of test cartridges during
the pilot implementation. As McCann et al. [26] recom-
mended to invest in POC EID rather than strengthening
the laboratory-based system, if Myanmar is to commit
to POC HIV EID testing, further consideration must be
given to an appropriate storage space at each site or the
development of a hub and spoke delivery system.
Accurate calculations of caseload per clinic and costs
data are essential in deciding on how to best distribute
resources in Myanmar, as are discussions with other
health programs, because the same Xpert machine can
be used for HIV viral load, hepatitis C diagnosis and
monitoring, human papillomavirus testing and tubercu-
losis testing and monitoring. As resources, workforce
and space are all limiting factors for the provision of
care in Myanmar, bringing these programs together and
using a hub-and-spoke model for sending samples from
sites with low caseload to sites with high caseload where
the POC machine is located [27] may add efficiencies to
the system in terms of optimising machine use, technical
expertise, maintenance and infrastructure support. This
will require utilization of the Xpert machine with mod-
ules appropriate for the caseload of the health facility in
order to avoid delays in result communication.
While our study provides information that is critical to
consider as POC EID testing is scaled up, it had some
limitations. The hospitals participating in this study were
all in the same region as the NHL. Their experiences of
sample transfer, results communication and access to
technical assistance with the NHL may differ from those
of more remote health facilities with greater geograph-
ical and transport challenges. Staff who operated the
Xpert machine in this study were all trained laboratory
personnel, and thus we are unable to extrapolate our re-
sults with respect to feasibility to non-laboratory staff.
Because this was part of a larger research study, dedi-
cated research staff were available to assist with tracing
and following up patients and liaising with the Xpert in-
country distributor for machine repair and procurement,
resources that will not be available upon national scale-
up, suggesting our study overestimates the real-world
efficiency of POC testing.
Conclusion
Despite staff shortages and infrastructure challenges,
healthcare workers and caregivers found the implemen-
tation of the POC EID test feasible and acceptable. The
simplicity of the test required minimal supervision, and
access to the NHL was an advantage at the pilot sites.
The national scale-up strategy needs a continual focus
on staff training, communication pathways and infra-
structure. Models of care involving non-laboratory-
trained personnel performing POC testing and cost
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effectiveness of POC EID in low caseload settings should
also be evaluated.
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